Showing results (91-100 of 109) with videos related to
Sort By:
Pageof 11
Diabetes, Obesity & Metabolism|July 26, 2024
Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors for the treatment of diabetes mellitus in liver transplant recipientsKatina Zheng, Amirhossein Azhie, Xiaoting You, et al.Circulation. Heart Failure|July 2, 2026
Effects of Acoramidis on Kidney Function in Transthyretin Amyloid CardiomyopathyJeffrey M Testani, Daniel P Judge, Barry A Borlaug, et al.Lancet (London, England)|December 18, 2023
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trialKatherine R Tuttle, Sibylle J Hauske, Maria Eugenia Canziani, et al.Kidney International|September 24, 2021
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney functionHiddo J L Heerspink, David Cherney, Douwe Postmus, et al.BMJ Open|May 25, 2022
Reporting quality of clinical trial protocols: a repeated cross-sectional study about the Adherence to SPIrit Recommendations in Switzerland, CAnada and GErmany (ASPIRE-SCAGE)Dmitry Gryaznov, Belinda von Niederhäusern, Benjamin Speich, et al.Journal of Clinical Epidemiology|May 24, 2021
Reporting quality of trial protocols improved for non-regulated interventions but not regulated interventions: A repeated cross-sectional studySzimonetta Lohner, Dmitry Gryaznov, Belinda von Niederhäusern, et al.Trials|October 29, 2020
Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projectsDmitry Gryaznov, Ayodele Odutayo, Belinda von Niederhäusern, et al.JACC. Heart Failure|June 15, 2024
Sodium Zirconium Cyclosilicate in HFrEF and Hyperkalemia: REALIZE-K Design and Baseline CharacteristicsMikhail N Kosiborod, David Cherney, Kim Connelly, et al.Journal of the American College of Cardiology|October 27, 2022
Cardiovascular Effects of Canagliflozin in Relation to Renal Function and AlbuminuriaAshish Sarraju, George Bakris, Christopher P Cannon, et al.Pediatric Diabetes|August 26, 2021
Tubular injury in diabetic ketoacidosis: Results from the diabetic kidney alarm studyFederica Piani, Isabella Melena, Cameron Severn, et al.Pageof 11